These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 36817086)
1. NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer. Liu W; Zhu M; Li X; Er L; Li S Dis Markers; 2023; 2023():9226712. PubMed ID: 36817086 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer. Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726 [TBL] [Abstract][Full Text] [Related]
3. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma. Zhang L; Song M; Zhang F; Yuan H; Chang W; Yu G; Niu Y J Histochem Cytochem; 2021 Mar; 69(3):165-176. PubMed ID: 33283625 [TBL] [Abstract][Full Text] [Related]
4. Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review. Togni L; Mascitti M; Sartini D; Campagna R; Pozzi V; Salvolini E; Offidani A; Santarelli A; Emanuelli M Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827592 [TBL] [Abstract][Full Text] [Related]
5. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma. Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696 [TBL] [Abstract][Full Text] [Related]
6. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer. Li J; Yue H; Yu H; Lu X; Xue X BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144 [TBL] [Abstract][Full Text] [Related]
7. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer. Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785 [TBL] [Abstract][Full Text] [Related]
8. Stromal nicotinamide N-methyltransferase orchestrates the crosstalk between fibroblasts and tumour cells in oral squamous cell carcinoma: evidence from patient-derived assembled organoids. Zhao H; Li R; Chen Y; Yang X; Shang Z Oncogene; 2023 Apr; 42(15):1166-1180. PubMed ID: 36823377 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma. Win KT; Lee SW; Huang HY; Lin LC; Lin CY; Hsing CH; Chen LT; Li CF Tumour Biol; 2013 Dec; 34(6):3923-31. PubMed ID: 23838801 [TBL] [Abstract][Full Text] [Related]
10. Nicotinamide N-Methyltransferase (NNMT) is Involved in Gastric Adenocarcinoma Immune Infiltration by Driving Amino Acid Metabolism. Lu J; Gui W; Tang S; Shi Q; Wang X; Huang L; Shen Y; Yang S; Xiang J; Yuan J; Mo J; Kong X; Huang M; Li X; Lu C Nutr Cancer; 2024; 76(8):745-759. PubMed ID: 38855943 [No Abstract] [Full Text] [Related]
11. Nicotinamide N-methyltransferase protein expression in renal cell cancer. Zhang J; Xie XY; Yang SW; Wang J; He C J Zhejiang Univ Sci B; 2010 Feb; 11(2):136-43. PubMed ID: 20104648 [TBL] [Abstract][Full Text] [Related]
14. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update. Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect. Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570 [TBL] [Abstract][Full Text] [Related]
16. Systematic pan-cancer analysis of the nicotinamide n-methyltransferase in human cancer. Cao L; Wu W; Deng X; Peng Y; Chen Y; Guo H; Wang L; Li X; Zhang Z; Shao Z Front Genet; 2022; 13():1000515. PubMed ID: 36386816 [TBL] [Abstract][Full Text] [Related]
17. Nicotinamide N-methyltransferase expression in squamous cell carcinoma of the vulva. Çelik ZE; Akar S; Fındık S; Aytekin E; Çelik Ç J Obstet Gynaecol; 2022 Aug; 42(6):2325-2330. PubMed ID: 35499473 [TBL] [Abstract][Full Text] [Related]
18. NAD Yang M; Wang B; Hou W; Zeng H; He W; Zhang XK; Yan D; Yu H; Huang L; Pei L; Li K; Qin H; Lin T; Huang J J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39067875 [TBL] [Abstract][Full Text] [Related]
19. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803 [TBL] [Abstract][Full Text] [Related]
20. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]